| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 08/16/2007 | WO2007075702A3 Treatment of nonalcoholic fatty liver disease using cholesterol lowering agents and h3 receptor antagonist/inverse agonist |
| 08/16/2007 | WO2007067964A3 Mucosal delivery of stabilized formulations of exendin |
| 08/16/2007 | WO2007048843A3 Imidazo-pyridine containing beta agonists, method for producing them and their use as drugs |
| 08/16/2007 | WO2007047112A3 Anti-myostatin antibodies |
| 08/16/2007 | WO2007000292A3 Novel targets and compounds useful in the treatment and/or prophylaxis of a cardiovascular disorder, dyslipidemia and atherosclerosis, and methods to identify such compounds |
| 08/16/2007 | WO2006079637A8 Heterocyclic tetracyclic tetrahydrofuran derivatives as 5ht2 inhibitors in the treatment of cns disorders |
| 08/16/2007 | WO2004007437A9 Urea-substituted and urethane-substituted acylureas, methods for the production thereof and their use as medicaments |
| 08/16/2007 | US20070191592 amidated peptide; stress-related conditions |
| 08/16/2007 | US20070191495 Lipase inhibitor |
| 08/16/2007 | US20070191435 Hydrochloride salt of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione |
| 08/16/2007 | US20070191429 Ppar activators |
| 08/16/2007 | US20070191419 (6R,8S)-6-(spiro[isobenzofuran-1-(3H), 4'-piperidin]-1'-ylmethyl)-5,6,7,8-tetrahydroquinolin-8-ol), exhibiting an antagonism to binding of nociceptin to opioid receptor-like-1 receptors, useful as medicines for diseases associated with pain and appetite control or memory and learning |
| 08/16/2007 | US20070191402 Method of searching substrate having antidiabetic activity |
| 08/16/2007 | US20070191392 Dipeptide nitrile cathespin k inhibitors |
| 08/16/2007 | US20070191347 Substituted sulfonamides and ureas useful for inhibiting kinase activity |
| 08/16/2007 | US20070191328 Isoquinoline compounds |
| 08/16/2007 | US20070191289 Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs |
| 08/16/2007 | US20070190634 Compositions useful as inhibitors of protein kinases |
| 08/16/2007 | US20070190612 31 Human Secreted Proteins |
| 08/16/2007 | US20070190136 Process for producing fenofibrate tablets |
| 08/16/2007 | US20070190106 Phosphorus-containing compounds & uses thereof |
| 08/16/2007 | US20070190076 A bacterial preparation consisting of freeze dried, non-denatured Mycobacterium bovis and water, in an amount effective to stimulate leukocytic regulatory cells, used for the prevention and/or the treatment of cancer, autoimmune diseases, allergies and tuberculosis; vaccines |
| 08/16/2007 | US20070190054 Prevention and treatment of complement-associated disorders |
| 08/16/2007 | US20070190041 Novel benzothiazepine and bensothiepine compounds |
| 08/16/2007 | US20070190021 Poly(diallylamine)-based bile acid sequestrants |
| 08/16/2007 | CA2641718A1 Bicyclic sphingosine 1-phosphate analogs |
| 08/16/2007 | CA2640476A1 Compounds and methods for modulating fx-receptors |
| 08/16/2007 | CA2640094A1 Treating vitamin d insufficiency and deficiency with 25-hydroxyvitamin d2 and 25-hydroxyvitamin d3 |
| 08/16/2007 | CA2637792A1 Combination of organic compounds |
| 08/16/2007 | CA2637771A1 Anthranilamide/2-amino-heteroarene carboxamide derivatives |
| 08/16/2007 | CA2634419A1 Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels |
| 08/16/2007 | CA2627900A1 Compounds and compositions as lxr modulators |
| 08/15/2007 | EP1818343A2 Antibodies against human IL-12 |
| 08/15/2007 | EP1817941A2 Compositions exhibiting inhibition of cyclooxygenase-2 |
| 08/15/2007 | EP1817323A1 Tetrahydropyrane derivatives for use as antidiabetics |
| 08/15/2007 | EP1817297A1 Dibenzyl amine compounds and derivatives |
| 08/15/2007 | EP1817078A1 Satiety emulsions and food compositions |
| 08/15/2007 | EP1817036A2 Modulators of muscarinic receptors |
| 08/15/2007 | EP1817027A2 Process for preparating enantiomerically pure fluvastatin sodium and a novel polymorphic form thereof |
| 08/15/2007 | EP1816915A1 Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2 |
| 08/15/2007 | EP1718641B1 Benzimidazole derivative and its use as a ii receptor antagonist |
| 08/15/2007 | EP1663244B1 Pteridine derivatives for the treatment of tnf-alpha-related diseases. |
| 08/15/2007 | EP1658292B1 Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors |
| 08/15/2007 | EP1554280B1 Antidiabetic beta-amino heterocyclic dipeptidyl peptidase inhibitors |
| 08/15/2007 | EP1480640B1 Peroxisome proliferator activated receptor modulators |
| 08/15/2007 | EP1442023B1 Crystalline sodium salt of telmisartan and the use of the same as an angiotensin antagonist |
| 08/15/2007 | EP1385825B1 Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives |
| 08/15/2007 | EP1363668B1 Combinations of bile acid sequestrant(s) and sterol absorption inhibitor(s) and treatments for vascular indications |
| 08/15/2007 | EP1354879B1 Dihydronaphthalene derivative compounds and drugs containing these compounds as the active ingredient |
| 08/15/2007 | EP1343488B1 Treatment of statin side effects |
| 08/15/2007 | EP1339458B1 Combination comprising an agent decreasing vegf activity and an agent decreasing egf activity |
| 08/15/2007 | EP1292568B1 Benzamide ligands for the thyroid receptor |
| 08/15/2007 | EP1254251B1 Neurosteroids as markers for alzheimer's disease |
| 08/15/2007 | EP0868176B1 Aminoguanidine for treating niddm |
| 08/15/2007 | CN1331864C Novel 2,5-diazabicyclo [2.2.1] heptane derivatives |
| 08/15/2007 | CN1331862C Di-aryl acid derivatives as PPAR receptor ligands |
| 08/15/2007 | CN1331860C Protein tyrosine phosphatase 1B inhibitor gamma-butyrolactones compounds and their preparation process and use |
| 08/15/2007 | CN1331848C Tricyclic steroid hormone nuclear receptor modulators |
| 08/15/2007 | CN1331526C Method for producing turmeric stable prepn. |
| 08/15/2007 | CN1331520C Slimming and blood fat reducing preparation |
| 08/15/2007 | CN1331503C Health-care preparation for reducing blood-fat and raising human-body immunity |
| 08/15/2007 | CN1331502C Chinese medicine composition |
| 08/15/2007 | CN1331476C Method for preparing coenzyme-A sublingual lozenge |
| 08/15/2007 | CN1331474C Medicinal composition for treating diabetes chronic complication and preparation method of effective component |
| 08/15/2007 | CN1331470C Method for preparing high stripping-degree hautriwaic glipizide capsule |
| 08/15/2007 | CN1331467C Ursine fat injection emulsion, and its prepn. method |
| 08/15/2007 | CN1331462C Self microemulsion of total dragon's blood flavone |
| 08/15/2007 | CN101018846A Method for producing unsaturated fatty acid concentrate |
| 08/15/2007 | CN101018790A 7-azaindoles and their use as PPAR agonists |
| 08/15/2007 | CN101018773A Hetroaryl benzamide derivatives for use as glk activators in the treatment of diabetes. |
| 08/15/2007 | CN101018561A Preparation for use of aspartate and vitamin B12 or biotin for regulating ketone bodies |
| 08/15/2007 | CN101018557A Carbohydrase inhibitors derived from chestnut and use thereof |
| 08/15/2007 | CN101018553A Methods and related compositions for reduction of fat |
| 08/15/2007 | CN101018550A Combination of DPP-IV inhibitors and compounds modulating 5-HT3 and/or 5-HT4 receptors |
| 08/15/2007 | CN101018546A (halobenzyloxy) benzylamino-propanamides as sodium and/or calcium channel selective modulators |
| 08/15/2007 | CN101018537A Wrinkle reduction agent, lipolysis accelerator, composition for external use on skin, and food or beverage composition |
| 08/15/2007 | CN101016313A Method of preparing soybean cephalin, cephalin tablet and active phosphatide granule |
| 08/15/2007 | CN101015678A Nutrient solution for treating patient intestinal dysfunction |
| 08/15/2007 | CN101015659A Health-care food for reducing blood sugar on the assistant role and its preparing process |
| 08/15/2007 | CN101015652A Health-care medicated wine for person in middle and old age |
| 08/15/2007 | CN101015646A Preparation for treating hyperlipoidemia and its preparing process and quality control method |
| 08/15/2007 | CN101015635A Functional foodstuff capable of regulating blood lipid and blood sugar |
| 08/15/2007 | CN101015627A Medicine composition for treating diabetes and its preparation |
| 08/15/2007 | CN101015603A Medicine composition with fat-reducing and bowel relaxing functions, preparing process and quality controlling means thereof |
| 08/15/2007 | CN101015597A Application of magnolia bark preparation in preparing medicine for treating diabetes and obesity |
| 08/15/2007 | CN101015575A Process for preparing bupleurum root dropping pills |
| 08/15/2007 | CN101015569A Silkworm powder expressing SOD and preparing method thereof |
| 08/15/2007 | CN101015566A Combined treatment method for type 2 diabetes by using camel milk and rosiglitazone maleate |
| 08/15/2007 | CN101015537A Preparation method of sodium iron chlorophyllin-ethyl cellulose microcapsule |
| 08/15/2007 | CN101015501A Injection composition of fat milk, amino acid and glucose packed with three-cavity bag and preparing method thereof |
| 08/15/2007 | CN101015386A Soft aloinose and preparation method thereof |
| 08/15/2007 | CN101015373A Lotus seed juice beverage |
| 08/15/2007 | CN101015355A Preparing method of squid melanin iron and application thereof |
| 08/15/2007 | CN101015352A Ocean functional food with weight-reducing and blood lipoid reducing functions |
| 08/15/2007 | CN101015351A Ultra-fine mulberry leaf powder used as food additives and preparing method thereof |
| 08/15/2007 | CN101015349A Health food for pregnant woman contaning pearl shell as primary component and its preparing process |
| 08/15/2007 | CN101015334A Chinese toon sauce with local flavor and its preparation |
| 08/15/2007 | CN101015329A Dry wheaten food with antihypelipidemic, antihyperglycemic, anti-hypertension, and thrombolytic functions and its processing method |
| 08/15/2007 | CN101015313A Lotus-leaf lotus-plumule herb tea |
| 08/15/2007 | CN101015312A Health care functional tea for conditioning subhealthy state |